disproportionately in erythrocytes in blood. 3 Therefore, we suspect that the fluctuation in dosing could be responsible for abrupt changes in plasma levels and thus, disproportionate carbonic anhydrase activity in susceptible individuals. Similarly, it implies that any insult to the red cells could result in an unexpected change of topiramate plasma levels.
Sir, Response to 'Comment on Topiramate maculopathy secondary to dose titration: first reported case'
We agree with Kozner et al that the maculopathy reported in our case 1 likely represents a mild form of the idiosyncratic reaction causing choroidal effusion, induced myopia, and angle-closure glaucoma that has been reported with topiramate and other sulfur-containing medications. In these cases, it is a consistently reported feature that the reaction generally occurs within days following commencement of the drug or an increase in dose. 2 In Kosner's case, 3 the reaction occurred 3 days after discontinuing topiramate and a sulfur-containing antibiotic, but the patient had commenced the medication 10 days prior to presentation. It is therefore difficult to be sure of the precise trigger in this case.
The important clinical point is that discontinuation of the drug leads to resolution of the symptoms. In some reports, resolution has possibly been hastened following the administration of IV methylprednisolone. 2 TLP defined as intraocular pressure (IOP) minus cerebrospinal fluid pressure (IOP − CSF-p) 2 is an interesting mechanical concept. However, there are some critical considerations concerning the interpretation and implementation of TLP we would like to mention.
First, as discussed by Siaudvytyte et al 1 both IOP and CSF-p used in the equation for TLPD are dynamic and fluctuate independently over time with numerous variables affecting both intracranial pressure and intraocular pressure measurements. Therefore, the estimation of TLPD would be best done by a simultaneous measurement of both IOP and CSF-p. None of the presented studies did it and thus all TLPD studies are dealing with two non-dependent and ever-changing variables to a definite time leaving us without a correlation that would fulfill the requirements of the simple physical equation of pressure, which is force over area at a definite time.
Second, in four out of the five analyzed studies, CSF-p has been measured by lumbar puncture and the lumbar CSF-p was extrapolated to the retrolaminar CSF-p. The assumption the lumbar CSF-p might equal the retrolaminar CSF-p only holds if the CSF-p is homogenous distributed in all CSF spaces, inclusively the subarachnoid space of the optic nerve. However, at least in NTG 3 CSF does not communicate freely between the intracranial subarachnoid space and that of the optic nerve. The optic canal is extremely narrow and due to the mechanosensitivity of meningothelial cells 4 that line the canal, the anatomy of the canal can change the anatomical pathway for CSF.
Third, as pressure is defined as force over area, the area involved in TLP needs to be known. The area in question is a complex and irregular arrangement of ovaloid circles that are arranged within an annulus 5 and is not known in any of the patients presented. Thus, the forces in the equation for TLPD cannot be calculated.
Given these missing information and uncertainties, the concept of TLP seems still premature.
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